The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Pharmacokinetics Services market was valued at US$ 622.2 million in 2023 and is anticipated to reach US$ 884.8 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmacokinetics Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacokinetics Services.
Report Scope
The Pharmacokinetics Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmacokinetics Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacokinetics Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company (Partial List)
- Evotec AG (Germany)
- Pacific BioLabs (US)
- GVK Biosciences Private Limited (India)
- Shanghai Medicilon Inc. (China)
- Pharmaceutical Product Development, LLC (US)
- Charles River Laboratories International, Inc. (US)
- PAREXEL International Corporation (US)
- Eurofins Scientific, Inc. (Luxembourg)
- Frontage Labs (US)
- SGS SA (Switzerland)
- LGC Limited (UK)
- Creative Bioarray (US)
- Certara, L.P. (Germany)
Segment by Type
- Small Molecules Pharmacokinetics Services
- Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Segment by Application
- Small & Medium Enterprise
- Large Enterprise
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacokinetics Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacokinetics Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Small Molecules Pharmacokinetics Services
1.2.3 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
1.3 Market by Application
1.3.1 Global Pharmacokinetics Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Small & Medium Enterprise
1.3.3 Large Enterprise
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacokinetics Services Market Perspective (2019-2030)
2.2 Pharmacokinetics Services Growth Trends by Region
2.2.1 Global Pharmacokinetics Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmacokinetics Services Historic Market Size by Region (2019-2024)
2.2.3 Pharmacokinetics Services Forecasted Market Size by Region (2025-2030)
2.3 Pharmacokinetics Services Market Dynamics
2.3.1 Pharmacokinetics Services Industry Trends
2.3.2 Pharmacokinetics Services Market Drivers
2.3.3 Pharmacokinetics Services Market Challenges
2.3.4 Pharmacokinetics Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacokinetics Services Players by Revenue
3.1.1 Global Top Pharmacokinetics Services Players by Revenue (2019-2024)
3.1.2 Global Pharmacokinetics Services Revenue Market Share by Players (2019-2024)
3.2 Global Pharmacokinetics Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacokinetics Services Revenue
3.4 Global Pharmacokinetics Services Market Concentration Ratio
3.4.1 Global Pharmacokinetics Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Services Revenue in 2023
3.5 Pharmacokinetics Services Key Players Head office and Area Served
3.6 Key Players Pharmacokinetics Services Product Solution and Service
3.7 Date of Enter into Pharmacokinetics Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacokinetics Services Breakdown Data by Type
4.1 Global Pharmacokinetics Services Historic Market Size by Type (2019-2024)
4.2 Global Pharmacokinetics Services Forecasted Market Size by Type (2025-2030)
5 Pharmacokinetics Services Breakdown Data by Application
5.1 Global Pharmacokinetics Services Historic Market Size by Application (2019-2024)
5.2 Global Pharmacokinetics Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmacokinetics Services Market Size (2019-2030)
6.2 North America Pharmacokinetics Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmacokinetics Services Market Size by Country (2019-2024)
6.4 North America Pharmacokinetics Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacokinetics Services Market Size (2019-2030)
7.2 Europe Pharmacokinetics Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmacokinetics Services Market Size by Country (2019-2024)
7.4 Europe Pharmacokinetics Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacokinetics Services Market Size (2019-2030)
8.2 Asia-Pacific Pharmacokinetics Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmacokinetics Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmacokinetics Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacokinetics Services Market Size (2019-2030)
9.2 Latin America Pharmacokinetics Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmacokinetics Services Market Size by Country (2019-2024)
9.4 Latin America Pharmacokinetics Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacokinetics Services Market Size (2019-2030)
10.2 Middle East & Africa Pharmacokinetics Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmacokinetics Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmacokinetics Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Evotec AG (Germany)
11.1.1 Evotec AG (Germany) Company Detail
11.1.2 Evotec AG (Germany) Business Overview
11.1.3 Evotec AG (Germany) Pharmacokinetics Services Introduction
11.1.4 Evotec AG (Germany) Revenue in Pharmacokinetics Services Business (2019-2024)
11.1.5 Evotec AG (Germany) Recent Development
11.2 Pacific BioLabs (US)
11.2.1 Pacific BioLabs (US) Company Detail
11.2.2 Pacific BioLabs (US) Business Overview
11.2.3 Pacific BioLabs (US) Pharmacokinetics Services Introduction
11.2.4 Pacific BioLabs (US) Revenue in Pharmacokinetics Services Business (2019-2024)
11.2.5 Pacific BioLabs (US) Recent Development
11.3 GVK Biosciences Private Limited (India)
11.3.1 GVK Biosciences Private Limited (India) Company Detail
11.3.2 GVK Biosciences Private Limited (India) Business Overview
11.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Introduction
11.3.4 GVK Biosciences Private Limited (India) Revenue in Pharmacokinetics Services Business (2019-2024)
11.3.5 GVK Biosciences Private Limited (India) Recent Development
11.4 Shanghai Medicilon Inc. (China)
11.4.1 Shanghai Medicilon Inc. (China) Company Detail
11.4.2 Shanghai Medicilon Inc. (China) Business Overview
11.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Introduction
11.4.4 Shanghai Medicilon Inc. (China) Revenue in Pharmacokinetics Services Business (2019-2024)
11.4.5 Shanghai Medicilon Inc. (China) Recent Development
11.5 Pharmaceutical Product Development, LLC (US)
11.5.1 Pharmaceutical Product Development, LLC (US) Company Detail
11.5.2 Pharmaceutical Product Development, LLC (US) Business Overview
11.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Introduction
11.5.4 Pharmaceutical Product Development, LLC (US) Revenue in Pharmacokinetics Services Business (2019-2024)
11.5.5 Pharmaceutical Product Development, LLC (US) Recent Development
11.6 Charles River Laboratories International, Inc. (US)
11.6.1 Charles River Laboratories International, Inc. (US) Company Detail
11.6.2 Charles River Laboratories International, Inc. (US) Business Overview
11.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Introduction
11.6.4 Charles River Laboratories International, Inc. (US) Revenue in Pharmacokinetics Services Business (2019-2024)
11.6.5 Charles River Laboratories International, Inc. (US) Recent Development
11.7 PAREXEL International Corporation (US)
11.7.1 PAREXEL International Corporation (US) Company Detail
11.7.2 PAREXEL International Corporation (US) Business Overview
11.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Introduction
11.7.4 PAREXEL International Corporation (US) Revenue in Pharmacokinetics Services Business (2019-2024)
11.7.5 PAREXEL International Corporation (US) Recent Development
11.8 Eurofins Scientific, Inc. (Luxembourg)
11.8.1 Eurofins Scientific, Inc. (Luxembourg) Company Detail
11.8.2 Eurofins Scientific, Inc. (Luxembourg) Business Overview
11.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Introduction
11.8.4 Eurofins Scientific, Inc. (Luxembourg) Revenue in Pharmacokinetics Services Business (2019-2024)
11.8.5 Eurofins Scientific, Inc. (Luxembourg) Recent Development
11.9 Frontage Labs (US)
11.9.1 Frontage Labs (US) Company Detail
11.9.2 Frontage Labs (US) Business Overview
11.9.3 Frontage Labs (US) Pharmacokinetics Services Introduction
11.9.4 Frontage Labs (US) Revenue in Pharmacokinetics Services Business (2019-2024)
11.9.5 Frontage Labs (US) Recent Development
11.10 SGS SA (Switzerland)
11.10.1 SGS SA (Switzerland) Company Detail
11.10.2 SGS SA (Switzerland) Business Overview
11.10.3 SGS SA (Switzerland) Pharmacokinetics Services Introduction
11.10.4 SGS SA (Switzerland) Revenue in Pharmacokinetics Services Business (2019-2024)
11.10.5 SGS SA (Switzerland) Recent Development
11.11 LGC Limited (UK)
11.11.1 LGC Limited (UK) Company Detail
11.11.2 LGC Limited (UK) Business Overview
11.11.3 LGC Limited (UK) Pharmacokinetics Services Introduction
11.11.4 LGC Limited (UK) Revenue in Pharmacokinetics Services Business (2019-2024)
11.11.5 LGC Limited (UK) Recent Development
11.12 Creative Bioarray (US)
11.12.1 Creative Bioarray (US) Company Detail
11.12.2 Creative Bioarray (US) Business Overview
11.12.3 Creative Bioarray (US) Pharmacokinetics Services Introduction
11.12.4 Creative Bioarray (US) Revenue in Pharmacokinetics Services Business (2019-2024)
11.12.5 Creative Bioarray (US) Recent Development
11.13 Certara, L.P. (Germany)
11.13.1 Certara, L.P. (Germany) Company Detail
11.13.2 Certara, L.P. (Germany) Business Overview
11.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Introduction
11.13.4 Certara, L.P. (Germany) Revenue in Pharmacokinetics Services Business (2019-2024)
11.13.5 Certara, L.P. (Germany) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
